OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 17, 2015
The company adds a few new arguments-as well as new stakeholder support-to its Citizen Petition on biosimilar naming.
August 15, 2015
The complex task of stabilizing proteins is made more challenging due to the limited number of approved excipients.
August 13, 2015
WuXi PharmaTech and TruTag Technologies successfully applied and detected TruTag's edible microtags on solid-dosage drug products and found no effect on dissolution.
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.
August 11, 2015
GEA's self-contained homogenizer is designed for laboratory applications, including cell dispersions.
The Biosimilars Forum, along with numerous House members, advocated for the use of unique J-codes for biosimilars in a recent letter to CMS.
August 10, 2015
The company’s Scotland-based facility has successfully completed a scheduled inspection by the UK’s MHRA; there were no critical or major observations noted.
August 07, 2015
Flexion will have a dedicated manufacturing suite at Patheon's Swindon, England facility for Flexion's osteoarthritis steroid drug product.
August 06, 2015
A study of root cause in stability samples suggests the need for tighter control of the sodium lauryl sulfate manufacturing processes.
August 05, 2015
US generics manufacturer Amneal acquires a former J&J plant in Ireland.